1984
DOI: 10.1177/014107688407701211
|View full text |Cite
|
Sign up to set email alerts
|

Retinopathy after Irradiation and Hyperbaric Oxygen

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

1986
1986
2024
2024

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(2 citation statements)
references
References 9 publications
0
1
0
Order By: Relevance
“…The treatment of radiation retinopathy also remains limited and is a serious challenge for modern medicine. Photodynamic therapy, laser photocoagulation, oral pentoxifylline, intravitreal steroid therapy, and hyperbaric oxygen have inconclusive results and limited efficacy [99][100][101][102][103][104][105][106][107][108][109][110][111][112]. Anti-vascular endothelial growth factor agents (anti-VEGF agents) reduce vascular permeability and inhibit the formation of abnormal new vessels.…”
Section: Prevention and Treatmentmentioning
confidence: 99%
“…The treatment of radiation retinopathy also remains limited and is a serious challenge for modern medicine. Photodynamic therapy, laser photocoagulation, oral pentoxifylline, intravitreal steroid therapy, and hyperbaric oxygen have inconclusive results and limited efficacy [99][100][101][102][103][104][105][106][107][108][109][110][111][112]. Anti-vascular endothelial growth factor agents (anti-VEGF agents) reduce vascular permeability and inhibit the formation of abnormal new vessels.…”
Section: Prevention and Treatmentmentioning
confidence: 99%
“… 11 Attempts have been made in the past to treat radiation retinopathy with laser photocoagulation, hyperbaric oxygen therapy, pentoxifylline therapy, and photodynamic therapy. 12 , 13 , 14 Vascular endothelial growth factor (VEGF) and other inflammatory and vasculogenic factors play a role in the pathogenesis of macular edema and neovascularization. 15 For this reason, the use of anti-VEGF agents has come to the fore in the treatment of radiation-related macular edema, neovascularization, and papillopathy.…”
Section: Introductionmentioning
confidence: 99%